4
Tentative scientific programme MSH 2011 28/4 (Thursday – pre-congress) 1000 – 1400 GIPAP events by Max Foundation 1400 – 2200 Registration & Poster mounting 1800 – 2000 Dinner talk by MSD – open to haematologists only MSD- sponsored speaker 29/4 (Friday – day 1) 0730 – 0830 Registration & Poster mounting 0830 – 0900 John Bosco Memorial Lecture: Haematology in V Puru Malaysia – the past, the present & the future 0900 – 0940 Plenary 1: Transcription factors and the M Osato molecular pathogenesis of acute leukaemias 0940 – 1010 Special lecture: The Malaysian National Haematology TC Ong Malignancy Database 1010 – 1030 Tea break 1030 – 1200 Symposium 1: Acute leukaemias a. Translating success of childhood ALL A Yeoh into adult ALL b. AML in younger adults (<60) – current A Teh management strategy c. AML in the elderly (>60) – has there been SC Ng any break through? 1200 – 1245 Lunch symposium 1 (Novartis): Management G Saglio of CML in the era of tyrosine kinase inhibitors 1245 – 1400 Lunch / Poster viewing

9 msh 2011 programme 9jan2011

Embed Size (px)

Citation preview

Page 1: 9 msh 2011   programme 9jan2011

Tentative scientific programme MSH 2011

28/4 (Thursday – pre-congress)

1000 – 1400 GIPAP events by Max Foundation

1400 – 2200 Registration & Poster mounting

1800 – 2000 Dinner talk by MSD – open to haematologists only MSD-sponsored speaker

29/4 (Friday – day 1)

0730 – 0830 Registration & Poster mounting

0830 – 0900 John Bosco Memorial Lecture: Haematology in V PuruMalaysia – the past, the present & the future

0900 – 0940 Plenary 1: Transcription factors and the M Osatomolecular pathogenesis of acute leukaemias

0940 – 1010 Special lecture: The Malaysian National Haematology TC OngMalignancy Database

1010 – 1030 Tea break

1030 – 1200 Symposium 1: Acute leukaemiasa. Translating success of childhood ALL A Yeoh

into adult ALLb. AML in younger adults (<60) – current A Teh

management strategyc. AML in the elderly (>60) – has there been SC Ng

any break through?

1200 – 1245 Lunch symposium 1 (Novartis): Management G Saglioof CML in the era of tyrosine kinase inhibitors

1245 – 1400 Lunch / Poster viewing

1400 – 1530 Symposium 2a: Myeloproliferative diseasesa. WHO classification and diagnosis of MPD CL Wongb. Management of myelofibrosis – an update KM Changc. Thrombocytosis – practical management issues SM Lim

1400 – 1530 Symposium 2b: Laboratory haematologya. Role of flow cytometry in MRD assessment TC Liu

in acute leukaemiasb. Laboratory aspect of CML management G Saglio

– an updatec. Advances in diagnostic histopathology of Pathma

lymphoma

1530 – 1550 Tea break

1550 – 1720 Symposium 3a: Infections in haematologya. Transfusion-associated infections – what CF Leong

Page 2: 9 msh 2011   programme 9jan2011

are the current issues? b. Chronic hepatitis B infection in haematology YL Kwong

patientsc. Management of fungal infections in haematology MSD-

sponsored speaker

1550 – 1720 Symposium 3b: Nursing issues in haematologya. Clinical issues in blood transfusion J Soob. Care of SCT patients B Tanc. Infection control in haematology patients SK Tan

30/4 (Saturday – day 2)

0800 – 0840 Plenary 2: Advances in cancer genetics and genomics WJ Chng

0840 – 0950 Symposium 4: Management of anaemiaa. Thalassaemia intermedia V Purub. Aplastic anaemia L Wongc. Cancer-related anaemia A Aziz Baba

0950 – 1010 Tea break

1010 – 1140 Symposium 5: Myelodysplastic syndromesa. WHO classification and laboratory diagnosis H Gudum

of MDSb. Management of MDS in the era of novel agents GG Ganc. Iron overload in MDS – scope of problem and AS Goh

management issues

1140 – 1220 Lunch symposium 2 (Janssen): State-of-the-science WJ Chngmanagement of multiple myeloma

1220 – 1330 Lunch / Poster viewing

1330 – 1500 Symposium 6: Plasma cell dyscrasiaea. Role of bisphosphonates in MM in the era of Haris AR

novel agents b. Role of ASCT in MM in the era of novel agents Fadilah AW c. Management of Waldenstrom`s macroglobulinaemia KM Chang

1500 – 1520 Tea break

1520 – 1650 Symposium 7a: Autoimmune haematologya. AIHA TC Liub. ITP SC Ngc. Acquired haemophilia Jameela S

1520 – 1650 Symposium 7b: Venous thromboembolisma. New anticoagulants – an update HJ Ngb. Thrombophilic screening – when and what to do? Sinari Sc. VTE in pregnancy – management issues HJ Ng

1700 – 1830 MSH Annual General Meeting MSH

Page 3: 9 msh 2011   programme 9jan2011

1/5/2011 (Sunday – day 3)

0800 – 0840 Plenary 3: Role of rituximab maintenance in lymphoid M Hertzbergmaliganancies

0840 – 1010 Symposium 8: Management issues in lymphomaa. Lymphoma in HIV patients V Sangkar b. Mantle cell lymphoma M Hertzbergc. Nasal NK/T-cell lymphoma YL Kwong

1010 – 1030 Tea break

1030 – 1200 Symposium 9: Stem cell issuesa. Leukaemic stem cell M Osatob. Non-haematopoietic stem cell transplantation SK Cheong – are we ready for prime time?c. National cord blood bank – is Malaysia ready? Roshida H

1200 – 1215 Prizes for poster winners & morphology quiz

1215 – 1300 Lunch symposium (NovoNordisk): Guideline for the Jameela Soff label use of rFVIIa in Malaysia

1300 - 1400 Lunch

See you next year !